Market Tracker

10/23 3:42am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

4.76
Data as of Oct 22
 -0.33 / -6.48%
Today’s Change
4.28
Today|||52-Week Range
19.11
-41.09%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close5.09
Today’s open5.08
Day’s range4.70 - 5.08
Volume84,136
Average volume (3 months)685,424
Market cap$112.0M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-33.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc+0.08+2.90%
QTNTQuotient Ltd+0.37+3.87%
TROVTrovagene Inc-0.21-4.72%
LPDXLipoScience Inc+0.01+0.19%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts